BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30841931)

  • 1. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.
    Xu W; Qian J; Zeng F; Li S; Guo W; Chen L; Li G; Zhang Z; Wang QJ; Deng F
    J Exp Clin Cancer Res; 2019 Mar; 38(1):114. PubMed ID: 30841931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-κB- and HDAC1-mediated expression and activation of uPA.
    Zou Z; Zeng F; Xu W; Wang C; Ke Z; Wang QJ; Deng F
    J Cell Sci; 2012 Oct; 125(Pt 20):4800-11. PubMed ID: 22797919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
    Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
    Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperactivated FRS2α-mediated signaling in prostate cancer cells promotes tumor angiogenesis and predicts poor clinical outcome of patients.
    Liu J; You P; Chen G; Fu X; Zeng X; Wang C; Huang Y; An L; Wan X; Navone N; Wu CL; McKeehan WL; Zhang Z; Zhong W; Wang F
    Oncogene; 2016 Apr; 35(14):1750-9. PubMed ID: 26096936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Kinase D2 and D3 Promote Prostate Cancer Cell Bone Metastasis by Positively Regulating Runx2 in a MEK/ERK1/2-Dependent Manner.
    Roy A; Prasad S; Chen Y; Chao Y; Liu Y; Zhao J; Wang QJ
    Am J Pathol; 2023 May; 193(5):624-637. PubMed ID: 36740185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKCζ in prostate cancer cells represses the recruitment and M2 polarization of macrophages in the prostate cancer microenvironment.
    Fan HH; Li L; Zhang YM; Yang J; Li MC; Zeng FY; Deng F
    Tumour Biol; 2017 Jun; 39(6):1010428317701442. PubMed ID: 28631559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AZGP1 deficiency promotes angiogenesis in prostate cancer.
    Wen RM; Qiu Z; Marti GEW; Peterson EE; Marques FJG; Bermudez A; Wei Y; Nolley R; Lam N; Polasko AL; Chiu CL; Zhang D; Cho S; Karageorgos GM; McDonough E; Chadwick C; Ginty F; Jung KJ; Machiraju R; Mallick P; Crowley L; Pollack JR; Zhao H; Pitteri SJ; Brooks JD
    J Transl Med; 2024 Apr; 22(1):383. PubMed ID: 38659028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cells promote metastasis of prostate cancer by enhancing autophagy.
    Zhao R; Bei X; Yang B; Wang X; Jiang C; Shi F; Wang X; Zhu Y; Jing Y; Han B; Xia S; Jiang Q
    J Exp Clin Cancer Res; 2018 Sep; 37(1):221. PubMed ID: 30200999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalein reduces angiogenesis in the inflammatory microenvironment via inhibiting the expression of AP-1.
    Huang Y; Miao Z; Hu Y; Yuan Y; Zhou Y; Wei L; Zhao K; Guo Q; Lu N
    Oncotarget; 2017 Jan; 8(1):883-899. PubMed ID: 27903990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB-related decrease of glioma angiogenic potential by graphite nanoparticles and graphene oxide nanoplatelets.
    Wierzbicki M; Sawosz E; Strojny B; Jaworski S; Grodzik M; Chwalibog A
    Sci Rep; 2018 Oct; 8(1):14733. PubMed ID: 30283098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin inhibits angiogenesis through thrombospondin-1 upregulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo.
    Yang F; Jiang X; Song L; Wang H; Mei Z; Xu Z; Xing N
    Oncol Rep; 2016 Mar; 35(3):1602-10. PubMed ID: 26676551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression.
    Su Y; Zhang Y; Zhao J; Zhou W; Wang W; Han B; Wang X
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3225-3243. PubMed ID: 34258652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity receptor for IgE stimulation activates protein kinase D augmenting activator protein-1 activity for cytokine producing in mast cells.
    Yamashita K; Gon Y; Shimokawa T; Nunomura S; Endo D; Miyata N; Hashimoto S; Van Lint J; Ra C
    Int Immunopharmacol; 2010 Mar; 10(3):277-83. PubMed ID: 19932769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells.
    Yuan J; Rozengurt E
    J Cell Biochem; 2008 Feb; 103(2):648-62. PubMed ID: 17570131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKCbetaII augments NF-kappaB-dependent transcription at the CCL11 promoter via p300/CBP-associated factor recruitment and histone H4 acetylation.
    Clarke DL; Sutcliffe A; Deacon K; Bradbury D; Corbett L; Knox AJ
    J Immunol; 2008 Sep; 181(5):3503-14. PubMed ID: 18714023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling.
    Wang T; Xing Y; Meng Q; Lu H; Liu W; Yan S; Song Y; Xu X; Huang J; Cui Y; Jia D; Cai L
    J Exp Clin Cancer Res; 2019 Apr; 38(1):174. PubMed ID: 31023336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C.
    Li J; Xiang S; Zhang Q; Wu J; Tang Q; Zhou J; Yang L; Chen Z; Hann SS
    J Exp Clin Cancer Res; 2015 May; 34(1):46. PubMed ID: 25971429
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Jaworski FM; Gentilini LD; Gueron G; Meiss RP; Ortiz EG; Berguer PM; Ahmed A; Navone N; Rabinovich GA; Compagno D; Laderach DJ; Vazquez ES
    Clin Cancer Res; 2017 Sep; 23(17):5135-5148. PubMed ID: 28512172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.